Background: Rodents express two isoforms of the angiotensin II type 1 (AT 1 ) receptor: AT 1A and AT 1B . It is unclear which receptor subtype mediates contraction in response to angiotensin II in various arteries. We tested the hypothesis that the AT 1B receptor is the predominant receptor that mediates contraction in the abdominal aorta in response to angiotensin II.
R
odents express two forms of the angiotensin II type 1 (AT 1 ) receptor: AT 1A and AT 1B .
1,2 However, the receptor subtypes that mediate angiotensin II-induced contraction of vascular smooth muscle have not been determined conclusively. Indirect evidence, obtained from wild-type and AT 1A receptor knockout mice, indicates that the AT 1A receptor is not solely responsible and implicates the AT 1B receptor as the subtype mediating vascular contraction to angiotensin II of large and small arteries. 3, 4 In studies using the kidneys of AT 1A or AT 1B null mice, we have shown that AT 1A and AT 1B receptors mediate angiotensin II contraction in the afferent arteriole, whereas the AT 1A receptor is the only receptor functionally present on the efferent arteriole. 5, 6 The goal of the present study was to directly test the hypothesis that AT 1B receptors mediate angiotensin II-induced contraction of the mouse abdominal aorta. No receptor agonists or antagonists yet exist that can differentiate between AT 1A and AT 1B receptors; however, a genetically engineered model is available. 7 To determine whether AT 1B receptors link to vascular smooth muscle contraction, we used isometric tension recording techniques to study the angiotensin II response of arteries obtained from wild-type and AT 1B receptor knockout mice.
Methods
The Animal Care and Use Committee of Louisiana State University Health Sciences Center (LSUHSC) approved the use of mice for these studies. Animal use followed guidelines set forth in the Guide for the Care and Use of Laboratory Animals (NIH publication no. 85-23, revised 1996). Furthermore, the method of sacrifice conformed to recommendations of the American Veterinary Medical Association Panel on Euthanasia. Male wild-type (n ϭ 9) and AT 1B receptor knockout mice (C57BL6J genetic back-ground; n ϭ 8) were bred in our colony at LSUHSC from breeder mice obtained from Thomas M. Coffman at Duke University and studied at 4 months of age. Genotyping of mice was performed by polymerase chain reaction (PCR) in duplicate on DNA obtained by tail biopsy, as we have recently described in detail 6 and illustrated in Fig. 1A . All animals were provided ad libitum access to food and water before the study.
Aortas were harvested from mice under pentobarbital sodium anesthesia (50 mg/kg intraperitoneally). For isometric tension recordings, the abdominal aorta near the iliac branch was cleaned of adipose and loose connective tissue, and cut into 2-mm rings. Tungsten wires were passed through the lumen and rings were suspended from micrometer-driven isometric force transducers (Multimyograph system 610M; Danish Myo Technology A/S, Denmark). Organ baths were filled with Kreb's solution containing 131 mmol/L NaCl, 25 mmol/L NaHCO 3 , 5 mmol/L KCl, 2.5 mmol/L CaCl 2 , 1.2 mmol/L MgSO 4 , 1.2 mmol/L NaH 2 PO 4 , and 10 mmol/L glucose, at pH 7.4. This solution was bubbled continuously with 95% O 2 and 5% CO 2 and maintained at 37°C. For each experiment, two rings from a wild-type mouse and two rings from an AT 1B receptor knockout mouse were studied at the same time. Optimal passive tension for each ring was determined by assessing the contraction to 60 mmol/L K ϩ at successively greater circumferential lengths (100 m linear displacements). Length was considered optimal when the active tension differed by less than 10% from that at the previous length. Contractions to angiotensin II (100 nmol/L), K ϩ (10 to 100 mmol/L), and U46619 (1 mol/L) were determined. The concentration of angiotensin II tested in the present study was based on the published work of Zhou et al. 3 Zhou et al presented angiotensin II responses of aortas obtained from wild-type and AT 1A knockout mice in the range of 0.1 nmol/L to 1 mmol/L and reported that 100 nmol/L angiotensin II produced a maximal response. 3 Group data are presented as the mean Ϯ standard error from n number of mice. Statistical tests are explained in relevant portions of the text and the criterion for significance was set as P Ͻ .05.
Results
In wild-type (n ϭ 9) and AT 1B receptor knockout mice (n ϭ 8), aortic passive tensions at optimal length were 12.2 Ϯ 0.1 and 12.00 Ϯ 0.1 mN, respectively. There were no significant differences in the passive length-tension curves between the aortas of wild-type and AT 1B receptor knockout mice. In contrast, aortic contractions in response to angiotensin II were significantly different between wildtype and AT 1B receptor knockout mice (Fig. 1) . Angiotensin II (100 nmol/L) elicited a 4.8 Ϯ 0.7 mN contraction in rings from wild-type mice, whereas the response in arteries from AT 1B receptor knockout mice was 0.6 Ϯ 0.1 mN (P Ͻ .001 by unpaired t test). Angiotensin II-induced contraction in aortic segments from AT 1B receptor knockout mice was only 13% of that in wild-type mice. In contrast, there were no differences in the K ϩ concentration-response curves with regard to magnitude or sensitivity (two-way analysis of variance; maximal K ϩ -induced contractions are shown in Fig. 1 ; EC 50 was 28 Ϯ 2 mmol/L in both groups). In addition, contractions to 1 mol/L U46619 were not different between arteries from wild-type and AT 1B receptor knockout mice. Aortic contractions elicited by the thromboxane A 2 mimetic were 14.3 Ϯ 1.1 and 14.5 Ϯ 1.3 mN in wild-type and AT 1B receptor knockout mice, respectively.
Discussion
Because rodents express two AT 1 receptor genes and it remains unclear which receptor subtype links to vasoconstriction in individual vascular beds, we tested the hypothesis that AT 1B receptors mediate angiotensin II-induced aortic smooth muscle contraction. No pharmacologic tool is available to differentiate between AT 1A and AT 1B receptors. However, a direct test of this hypothesis was made possible by using AT 1B receptor knockout mice. Segments of abdominal aorta were mounted on isometric force transducers and contractions to angiotensin II, K ϩ , and U46619 were determined. Angiotensin II-induced aortic contractions were virtually absent in AT 1B knockout mice, as responses were approximately one-tenth of those Genotyping for the AT 1B gene requires two PCR reactions, as described in detail previously. 6 The 700-bp product in wild-type (wt) mice is from amplification of the AT 1B gene, whereas the 1300-bp product in AT 1B receptor knockout (KO) mice results from insertion of a neomycin resistance cassette. (B) Isometric tension recordings from a representative wt and a KO mouse show contractions elicited by angiotensin II. (C) Group data (n ϭ 9 wt, 8 KO mice) illustrate reduced angiotensin II-induced contraction in AT 1B receptor knockout mice (*P Ͻ .001 by unpaired t test), whereas the responses to U46619 and KCl are not altered.
observed in wild-type mice. In contrast, contractions in response to membrane depolarization (K ϩ ) were similar in aortic segments from wild-type and AT 1B knockout mice. Furthermore, contraction to another G-protein-coupled agonist, the thromboxane A2 mimetic U46619, was not different between arteries from wild-type and AT 1B knockout mice. Thus, we conclude that AT 1B receptors mediate aortic contraction to angiotensin II, and that AT 1B receptor knockout mice do not suffer from any generalized decrease in smooth muscle function. Targeted ablation of the AT 1B receptor allows definitive assignment of this receptor to angiotensin II-induced contraction in the mouse abdominal aorta, a response mediated by the single known AT 1 receptor class in human vascular smooth muscle. 8 Our results facilitate the interpretation of other studies in rodent models aimed at understanding the contribution of angiotensin II-induced smooth muscle contraction to the control of vascular resistance, and thus blood pressure. The existence of AT 1A and AT 1B receptors in rodents represents a notable distinction from human physiology. However, understanding the roles that each receptor subtype plays allows more direct comparison to human blood vessels. Perhaps analogous to AT 1A and AT 1B receptors in rodents, the human AT 1 receptor gene is alternatively spliced to produce receptors with different functional properties. 9 Rodent AT 1A and AT 1B receptors arise as the products of separate genes, yet there is 94% amino acid sequence identity between the two isoforms. 10 Despite the genetic similarity, tissue distributions of AT 1A and AT 1B receptors differ dramatically and change with age. 11 Currently, our understanding of the physiologic roles of rodent AT 1A and AT 1B receptors remains incomplete. This is complicated by the fact that the role of AT 1A and AT 1B receptors in smooth muscle may vary by anatomic location in one rodent species. For example, the effects of angiotensin II on renal blood flow in AT 1A knockout mice is only partially impaired, suggesting functional coupling to AT 1B receptors. 12 This may be because afferent arteriole vasoconstriction is mediated by both AT 1A and AT 1B receptors, whereas efferent arteriolar vasoconstriction is mediated solely by AT 1A receptors. 5 Our data support previous indirect evidence that AT 1B receptors mediate aortic contraction. 3 Furthermore, our findings confirm that transgenic and knockout technology promise to provide novel information regarding vascular reactivity, but that the models must first be characterized and understood. This is particularly relevant to AT 1 receptor isoforms, as absence of one type can be compensated for by changes in the expression of the other. 13 Such compensation is not the case for AT 1B receptors in this artery, as these receptors apparently provide the critical link between angiotensin II and abdominal aortic contraction in mice.
